Gilead

Gilead Sciences Scores First Win With Late-Stage Hep C Study
TheStreet.com
Tue, 11/27/12 - 10:30 am
hepatitis C
Gilead
sofosbuvir
First 90 Days of 2013 Are Live or Die For These Biotech Stocks
TheStreet.com
Mon, 11/19/12 - 02:00 pm
Oncothyreon
Celsion
Arena Pharmaceuticals
NuPathe
Hemispherx
Amarin
Biogen Idec
Gilead
Hyperion Therapeutics
Celgene
Raptor Pharmaceuticals
Dynavax
Zogenix
Impax Labs
Gilead's single tablet Stribild shows positive results in two HIV studies
Yahoo/Fly on the Wall
Thu, 11/15/12 - 11:11 am
HIV
Stribild
Gilead
All Is Well That Ends Well; Acquisition By Gilead Sciences Pays Off
Seeking Alpha
Wed, 11/14/12 - 12:32 pm
Gilead
M&A
hepatitis C
Does Achillion Have a Place in the HCV Market of the Future?
Yahoo/Reuters
Wed, 11/14/12 - 12:30 pm
Achillion
hepatitis C
Abbott Labs
Gilead
ACH-1625
Vertex Pharmaceuticals
3 Reasons Why Not All Hep C Data Is Created Equal
Motley Fool
Tue, 11/13/12 - 11:51 am
hepatitis C
Gilead
Abbott Labs
Vertex Pharmaceuticals
Achillion
Idenix
Gilead Shares Hit All-Time High On Positive Trial For Hep C Drug
Yahoo/Investors Business Daily
Tue, 11/13/12 - 11:13 am
hepatitis C
Gilead
GS-5885
GS-7977
Gilead Climbs on Study Results of Hepatitis C Combo
Bloomberg
Mon, 11/12/12 - 11:02 am
Gilead
hepatitis C
sofosbuvir
GS-5885
GS-7977
Exelixis, Celgene, Gilead Sciences, Dynavax See Key Dates in November
Minyanville
Wed, 10/31/12 - 11:52 am
Exelixis
Celgene
Gilead
Dynavax
This Big Biotech Rejoices, but for How Long?
Motley Fool
Thu, 10/25/12 - 10:55 am
Gilead
Gilead net drops on higher expenses
Marketwatch
Tue, 10/23/12 - 04:31 pm
Gilead
earnings
Bayer lung drug shows promise in pulmonary hypertension
Reuters
Mon, 10/22/12 - 12:09 pm
Bayer
PAH
Actelion
Gilead
Riociguat
Tracleer
5 Things to Watch This Week in the Health-Care Sector
Motley Fool
Mon, 10/22/12 - 10:52 am
Regeneron
Eyela
Gilead
GS-7977
Merck
Eli Lilly
Singulair
Molina Healthcare
BioCryst, Presidio Merger Creates Yet Another Competitor in the HCV Segment
Yahoo/Fly on the Wall
Thu, 10/18/12 - 01:10 pm
Biocryst
Presidio
hepatitis C
M&A
Gilead
Abbott Labs
Achillion
Gilead shares should advance on upcoming data, says RBC Capital
The Fly on the Wall
Tue, 10/16/12 - 10:43 am
Gilead
hepatitis C
Abbott Hep C Therapy Achieves Almost-Perfect Cure Rate
TheStreet.com
Mon, 10/15/12 - 11:37 am
Abbott Labs
hepatitis C
ABT-450
ABT-267
ABT-333
Gilead
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
Achillion Back On The Hep C Roller Coaster Of Love
Seeking Alpha
Wed, 09/19/12 - 11:30 am
Achillion
hepatitis C
Abbott Labs
Gilead
JNJ
Merck
Pfizer
ACH-1625
Gilead Sciences Makes Headlines With HIV Prevention Pill, Looks to Hepatitis Drugs for Future
Minyanville
Fri, 09/14/12 - 12:23 pm
Gilead
HIV
hepatitis C
GS-7977
Truvada
High-End HIV Drug Stribild To Set Gilead Sciences Apart
Seeking Alpha
Wed, 09/5/12 - 06:56 pm
HIV
Gilead
Stribild

Pages